Progesterone Clinical Trial
Official title:
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst
The aim of this study is to determine whether the use of progesterone only pills has a beneficial effect over the expectant management of functional ovarian cyst or not , through a sample of female patients within the reproductive years
An ovarian cyst is a common gynecological problem and is divided into 2 main categories;
physiological and pathological In relative frequency, functional cysts account for about 24%
of all ovarian cysts, benign cysts 70% and malignant 6% Functional cysts are the most common
masses seen in the premenopausal ovary and are estimated to affect 8%-20% of
reproductive-aged women
Pain or discomfort in the lower abdomen Severe pain from torsion (twisting) or rupture - Cyst
rupture is characterized by sudden, sharp, unilateral pelvic pain; this can be associated
with trauma, exercise, or coitus. Cyst rupture can lead to peritoneal signs, abdominal
distention, and bleeding (which is usually self-limited) Discomfort with intercourse,
particularly deep penetration Changes in bowel movements such as constipation Pelvic pressure
causing tenesmus or urinary frequency Menstrual irregularities Precocious puberty and early
menarche in young children Abdominal fullness and bloating Indigestion, heartburn, or early
satiety Hyperpyrexia - This may result from some complications of ovarian cysts, such as
ovarian torsion Adnexal or cervical motion tenderness In current clinical practice ,
gynecologists treat functional ovarian cysts with either oral Contraceptive pills or
expectant management alone. we presume using progesterone only pills for treatment of
functional ovarian cyst
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03340701 -
Pharmacokinetics of Progesterone in Pregnancy
|
Phase 1 | |
| Completed |
NCT04535973 -
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
|
||
| Completed |
NCT03740568 -
Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes.
|
N/A | |
| Terminated |
NCT04140968 -
Progesterone and Resting Energy Expenditure
|
Phase 4 | |
| Completed |
NCT03677336 -
Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI
|
Phase 4 | |
| Completed |
NCT05742503 -
Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level
|
||
| Completed |
NCT02323347 -
Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer
|
N/A | |
| Completed |
NCT00264407 -
Neural Changes in the Aging Auditory System
|
Phase 1 | |
| Recruiting |
NCT04124913 -
Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles
|
Phase 4 | |
| Completed |
NCT03734770 -
Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support
|
N/A | |
| Completed |
NCT04253470 -
Debate on Progesterone Elevation on the Day of Triggering
|
||
| Completed |
NCT04769401 -
Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle
|
N/A | |
| Recruiting |
NCT05481684 -
The Importance of Embryo Transfer Day Progesterone Value in Natural Cycle Frozen Embryo Transfers and the Evaluation of the Effect of Rescue Therapy on Pregnancy Outcomes in Patients With Low Progesterone Levels
|
N/A | |
| Completed |
NCT05276531 -
Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support
|
N/A |